Monday, October 22, 2018

Qpex Biopharma Finds $33M For Antibiotics Development

San Diego-based Qpex Biopharma announced this morning that it has raised $33M in a Series A funding round, to launch its efforts to battle drug-resistant infections. According to Qpex, the funding was led by New Enterprise Associates, and also included Adams Street Partners, LYZZ Capital, Hatteras Venture Partners and Stanford University Draper Fund. The company also said it has an agreemen

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---